VMC
53
-4
AZO
50
-5
MLM
45
-5
EQT
51
-3
DOV
65
-4
CMS
60
2
F
56
-3
MCD
52
-5
MSI
72
-3
XOM
42
-6
TRIP
50
-4
MO
60
-2
K
51
-3
INTC
41
4
JWN
48
-2
GD
41
-4
DIS
85
3
LB
30
4
AON
54
2
NWSA
62
-7
VMC
53
-4
AZO
50
-5
MLM
45
-5
EQT
51
-3
DOV
65
-4
CMS
60
2
F
56
-3
MCD
52
-5
MSI
72
-3
XOM
42
-6
TRIP
50
-4
MO
60
-2
K
51
-3
INTC
41
4
JWN
48
-2
GD
41
-4
DIS
85
3
LB
30
4
AON
54
2
NWSA
62
-7
Financhill
Back

Trinity Biotech PLC Vs. Akari Therapeutics PLC Industry Stock Comparison

Sell
13

TRIB
Trinity Biotech PLC

Last Price:
1.37
Seasonality Move:
6.79%
Sell
22

AKTX
Akari Therapeutics PLC

Last Price:
2.01
Seasonality Move:
-8.33%
Sell
13
Trinity Biotech PLC (TRIB) is a Sell

Is Trinity Biotech PLC a Buy, Sell or Hold?

  • The current Trinity Biotech PLC [TRIB] share price is $1.37. The Score for TRIB is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • TRIB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $2.08. The Score for AKTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRIB Stock Price Chart

What is Trinity Biotech PLC's stock price today?

  • The Trinity Biotech PLC share price today is $1.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing selling pressure, which indicates risk of future bearish movement.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $2.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 36.72 Sell
Chaikin Money Flow: -34438 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.54 - 1.88) Sell
Bollinger Bands (100): (1.44 - 2.64) Sell

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 34.79 Sell
Chaikin Money Flow: 10527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.21 - 2.55) Sell
Bollinger Bands (100): (2.58 - 3.7) Sell

TRIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.58 Sell
20-day SMA: 1.7 Sell
50-day SMA: 1.57 Sell
200-day SMA: 2.07 Sell
8-day EMA: 1.56 Sell
20-day EMA: 1.64 Sell
50-day EMA: 1.72 Sell
200-day EMA: 2.15 Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.29 Sell
20-day SMA: 2.34 Sell
50-day SMA: 2.75 Sell
200-day SMA: 2.56 Sell
8-day EMA: 2.27 Sell
20-day EMA: 2.39 Sell
50-day EMA: 2.67 Sell
200-day EMA: 2.98 Sell

Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and an increase next year of $0.84 per share.

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Trinity Biotech PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):